Who owns PROCESSA PHARMACEUTICALS INC?
- CUSIP Number: 74275c304
Tip: Access positions for across all investors
Analyze quarterly positions in Processa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Processa Pharmaceuticals stock
Who bought or sold PROCESSA PHARMACEUTICALS INC this quarter?
There are no current stakeholders of Processa Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Processa Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Stonepine Capital Management | Sep 2025 | 1.0M | $198k |
| Geode Capital Management | Sep 2025 | 303k | $58k |
| Vanguard Group | Sep 2025 | 288k | $55k |
| Cubist Systematic Strategies | Jun 2025 | 42k | $8.6k |
| Virtu Financial | Sep 2025 | 41k | $8.0k |
| Two Sigma Securities | Sep 2025 | 36k | $7.0k |
| Intl Fcstone | Sep 2025 | 19k | $3.6k |
| Sassicaia Capital Advisers | Sep 2025 | 16k | $3.1k |
| Miracle Mile Advisors | Sep 2025 | 10k | $1.9k |
| Tower Research Capital | Sep 2025 | 2.4k | $458.977400 |
| Jones Financial Companies, L.L | Sep 2025 | 188.00 | $40.006400 |